Delancey has submitted plans to deliver up to 200,000 sq ft of science and technology space on a brownfield site in Islington, North London.
The proposals for the site at 176-178 York Way, which is situated in London’s growing Knowledge Quarter and Innovation District, include 130,000 sq ft of research and laboratory space.
Designed by architects Kohn Pedersen Fox, the Delancey scheme is targeting a NABERS 4.5+ star rating for the all-electric development.
Nathan Watt, development director at Delancey, said: “At Delancey, we’ve worked on some of the UK’s largest regeneration projects, and we have a track record of delivering on complex and constrained sites, building exceptional assets on behalf of client funds. Our plans for York Way will be no different – this is an exciting opportunity to realise a new hub for science and innovation in one of the most established life science and technology markets in the world. This is only the start of our journey, and we look forward to continuing our work with residents and Islington Council to bring these plans to fruition”.
Dan Dawe, investment director at Delancey, added: “Our current investment into King’s Cross is underpinned by strong underlying secular tailwinds that support the science and technology sector, and our strong belief that King’s Cross will be the pre-eminent real estate cluster in London for innovative science going forward.
“Following a process of strategic land assembly, detailed design work and engagement with Islington Council and residents, we are excited by the opportunity to bring forward our proposals to deliver one of King’s Cross first ground up, purpose-built science and technology buildings. Our ambition is to offer a genuine point of difference in the market, whilst also ensuring we rejuvenate a prominent area of Islington.”
If the plans are approved Delancey hopes to make a start on site next year with completion scheduled for 2028. CBRE provided strategic advice on the site.
